Wix Announces 20 Workforce Reduction Amid AIDriven Restructuring Alibaba Unveils Upgraded Zhenwu AI Chip and NextGeneration Large Language Model Trump Postpones AI Executive Order Signing Cites Concerns Over Potential Blocking Effects Dow Leads Wall Street Higher as Healthcare and Tech Stocks Rally Amazoncoms Unwavering Grip on Wall Street Why Analysts Remain Focused Gentell CEO Navigates Oil Price Shock Amid Strait of Hormuz Crisis Protara Therapeutics Q1 2026 Earnings EPS Beat Despite No Revenue Stock Declines Medallion Financial Corp MFIN Q1 2026 Earnings Profitability Miss Pressures the Stock GBFH Q1 2026 Earnings Significant EPS Miss Amid Challenging Operating Conditions Tevogen Bio Holdings Q4 2025 Earnings NarrowerthanExpected Loss Fails to Lift Shares VRME Q4 2025 Earnings EPS Misses Estimates Amidst Challenging Quarter NWTG Q1 2026 Earnings Deep EPS Miss Sends Shares Lower Amid Unreported Revenue GPAct III Acquisition Corp GPAT Holds Steady Near 1083 Amid Low Volatility Hingham Institution for Savings HIFS Holds Steady After Modest Gain Support and Resistance Levels in Focus Iron Mountain IRM Shows Slight Pullback as Stock Tests Key Support Levels JBG SMITH Properties JBGS Posts Modest Gains Amid Mixed Market Signals Damora Therapeutics DMRA Holds Steady Near Support Technical Analysis of Key Levels Consumer Sentiment Hits Record Low in May Amid IranDriven Gas Price Surge Duos Technologies Group Inc DUOT Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Revenue Uncertainty Dynamix Corporation III Unit DNMXU Holds Steady at 1014 as Stock Consolidates Between Key Levels Context Therapeutics Inc CNTX Shows Modest Gains Near Key Resistance Level BrightView Holdings BV Edges Higher Testing Key Resistance Zone Franklin Resources BEN Holds Steady Near Key Support as Asset Manager Faces Headwinds Comcast Holdings ZONES CCZ Holds Steady at 639 as RangeBound Trading Persists Taylor Morrison Home Corporation TMHC Edges Higher as Housing Sector Consolidates KLX Energy Services KLXE Slides 55 as Energy Sentiment Sours Endava DAVA Faces Continued Pressure as Shares Slide Over 1